HIV-1 Genotypic Drug Resistance Mutation Analysis, with Reflex to Phenotypic Drug Resistance Prediction, Plasma
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Identification of key HIV genotypic mutations associated with resistance to nucleotide reverse-transcriptase inhibitors, nonnucleotide reverse-transcriptase inhibitors, and protease inhibitors
Reflex Tests Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
|Test ID||Reporting Name||Available Separately||Always Performed|
|VPHIV||HIV-1 Phenotypic Resist Prediction||No||No|
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
If HIV type 1 genotypic drug resistance mutation analysis detects drug resistance mutations, then VPHIV/88781 HIV-1 Phenotypic Drug Resistance Prediction (Add-On) will be performed at an additional charge.
See HIV Treatment Monitoring Algorithm in Special Instructions.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
GHIVR/88782: Reverse Transcription-Polymerase Chain Reaction (RT-PCR)/DNA Sequencing
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
VPHIV/88781: Virtual Phenotype
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
HIV-1 Geno Reflex to Pheno Predict